H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 79 Citations 26,236 276 World Ranking 701 National Ranking 58
Medicine D-index 79 Citations 25,593 277 World Ranking 10087 National Ranking 907

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Antibody
  • Immune system

Her primary scientific interests are in Antibody, Immunology, Antigen, Molecular biology and Chronic lymphocytic leukemia. Her Antibody research integrates issues from Gene and Immune system. Freda K. Stevenson interconnects Cancer research, Signal transduction and Disease in the investigation of issues within Immunology.

Her studies in Cancer research integrate themes in fields like Phosphorylation and [email protected] Her Chronic lymphocytic leukemia research incorporates themes from Immunoglobulin M, Germline mutation, breakpoint cluster region and Naive B cell. Her research in Naive B cell intersects with topics in Monoclonal B-cell lymphocytosis and Memory B cell.

Her most cited work include:

  • Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. (2375 citations)
  • Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. (2375 citations)
  • CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. (578 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of study are Immunology, Antibody, Antigen, Molecular biology and Chronic lymphocytic leukemia. Her Lymphoma research extends to the thematically linked field of Antibody. Her Antigen research is multidisciplinary, relying on both Cytotoxic T cell and Virology.

Her work in Molecular biology addresses issues such as Gene, which are connected to fields such as Follicular lymphoma and DNA. Her Chronic lymphocytic leukemia research includes elements of Cancer research, breakpoint cluster region and B-cell receptor. Her research integrates issues of Apoptosis and Phosphorylation in her study of Cancer research.

She most often published in these fields:

  • Immunology (47.24%)
  • Antibody (39.63%)
  • Antigen (33.60%)

What were the highlights of her more recent work (between 2012-2020)?

  • Cancer research (16.54%)
  • Immunology (47.24%)
  • Chronic lymphocytic leukemia (17.06%)

In recent papers she was focusing on the following fields of study:

Her main research concerns Cancer research, Immunology, Chronic lymphocytic leukemia, Antigen and [email protected] The concepts of her Cancer research study are interwoven with issues in Cell culture, CD19, Interleukin 4, PI3K/AKT/mTOR pathway and Kinase. Her study looks at the relationship between Immunology and topics such as Phenotype, which overlap with Mutation.

The study incorporates disciplines such as breakpoint cluster region, B-cell receptor and Signal transduction in addition to Chronic lymphocytic leukemia. As part of the same scientific family, Freda K. Stevenson usually focuses on Antigen, concentrating on Molecular biology and intersecting with Surface Immunoglobulin, Mannose, Glycosylation, Peptide sequence and Gene. Her [email protected] study also includes fields such as

  • Methylation that intertwine with fields like Epigenetics and CpG site,
  • Somatic hypermutation which is related to area like Germinal center, Follicular lymphoma, Chemoimmunotherapy and Stromal cell.

Between 2012 and 2020, her most popular works were:

  • Chronic lymphocytic leukaemia. (192 citations)
  • The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy (65 citations)
  • Correction: Chronic lymphocytic leukaemia (60 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Antibody
  • Immune system

Freda K. Stevenson mostly deals with Immunology, Chronic lymphocytic leukemia, Cancer research, breakpoint cluster region and Antibody. Her Immunology research focuses on Antigen and Cytokine. Freda K. Stevenson works on Chronic lymphocytic leukemia which deals in particular with [email protected]

Her Cancer research study deals with B-cell receptor intersecting with Ibrutinib, Translational regulation, Protein biosynthesis, eIF4A and Translation. Her breakpoint cluster region research focuses on Cell biology and how it relates to Clone, Follicular lymphoma, Chromatin, B cell and Germinal center. Her work investigates the relationship between Antibody and topics such as Vaccination that intersect with problems in DNA vaccination, Cancer, Multiple myeloma and ELISPOT.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Terry J. Hamblin;Terry J. Hamblin;Zadie Davis;Zadie Davis;Anne Gardiner;Anne Gardiner;David G. Oscier;David G. Oscier.
Blood (1999)

3747 Citations

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

Terry J. Hamblin;Jenny A. Orchard;Rachel E. Ibbotson;Zadie Davis.
Blood (2002)

892 Citations

Chronic lymphocytic leukemia : revelations from the B-cell receptor

Freda K. Stevenson;Federico Caligaris-Cappio.
Blood (2004)

563 Citations

DNA vaccines: precision tools for activating effective immunity against cancer.

Jason Rice;Christian H. Ottensmeier;Freda K. Stevenson.
Nature Reviews Cancer (2008)

501 Citations

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

Catherine A. King;Myfanwy B. Spellerberg;Delin Zhu;Jason Rice.
Nature Medicine (1998)

497 Citations

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.

Stuart Lanham;Terry Hamblin;David Oscier;Rachel Ibbotson.
Blood (2003)

435 Citations

B-cell receptor signaling in chronic lymphocytic leukemia

Freda K. Stevenson;Sergey Krysov;Andrew J. Davies;Andrew J. Steele.
Blood (2011)

401 Citations

Differential Rates of Somatic Hypermutation in VH Genes Among Subsets of Chronic Lymphocytic Leukemia Defined by Chromosomal Abnormalities

David G. Oscier;David G. Oscier;Andrew Thompsett;Andrew Thompsett;Delin Zhu;Delin Zhu;Freda K. Stevenson;Freda K. Stevenson.
Blood (1997)

332 Citations

Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma

Delin Zhu;Helen McCarthy;Christian H. Ottensmeier;Peter Johnson.
Blood (2002)

287 Citations

VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities.

V Pascual;K Victor;M Spellerberg;T J Hamblin.
Journal of Immunology (1992)

268 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Freda K. Stevenson

Richard Rosenquist

Richard Rosenquist

Karolinska Institute

Publications: 128

Paolo Ghia

Paolo Ghia

Vita-Salute San Raffaele University

Publications: 103

Nicholas Chiorazzi

Nicholas Chiorazzi

Feinstein Institute for Medical Research

Publications: 98

Gianluca Gaidano

Gianluca Gaidano

University of Eastern Piedmont Amadeo Avogadro

Publications: 89

Kanti R. Rai

Kanti R. Rai

Hofstra University

Publications: 88

Thomas J. Kipps

Thomas J. Kipps

University of California, San Diego

Publications: 86

Michael J. Keating

Michael J. Keating

The University of Texas MD Anderson Cancer Center

Publications: 83

John C. Byrd

John C. Byrd

University of Cincinnati

Publications: 76

Michael Hallek

Michael Hallek

University of Cologne

Publications: 75

Stephan Stilgenbauer

Stephan Stilgenbauer

University of Ulm

Publications: 74

David Oscier

David Oscier

Royal Bournemouth Hospital

Publications: 71

Davide Rossi

Davide Rossi

European Society for Medical Oncology

Publications: 69

Neil E. Kay

Neil E. Kay

Mayo Clinic

Publications: 65

John G. Gribben

John G. Gribben

Queen Mary University of London

Publications: 65

Ronald Levy

Ronald Levy

Stanford University

Publications: 63

Elias Campo

Elias Campo

University of Barcelona

Publications: 63

Something went wrong. Please try again later.